CoreComm Internet

Features

Make this your home page

Approval of a cheap version of HIV-prevention shot lenacapavir raises hopes in low-income countries

The U. S. Food and Drug Administration has approved a generic version of the world’s only twice-a-year shot to prevent HIV — a big step toward making the drug available inexpensively and more quickly in 120 low- and middle-income countries. The announcement was made on Monday morning by the manufacturer and organizations that helped to speed up development of the medication, called lenacapavir. The drug is expected to cost $40 a year per person in the countries where it will be available,...

Read More
 

----------
Copyright 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

CoreComm is not responsible for content on external sites. Please review the privacy and security policies of each vendor before making online purchases or providing personal information. Forecast Information Provided by AccuWeather.